Orexin and Central Regulation of Cardiorespiratory System

Vitamins and Hormones

Volumn 89, Issue , 2012, Pages 159-184

  Shahid, Israt Z ^a,b   Rahman, Ahmed A ^a,b   Pilowsky, Paul M ^a  

^a MACQUARIE UNIVERSITY   (Australia)

^b KHULNA UNIVERSITY   (Bangladesh)

Author keywords

Blood pressure; Orexin; Respiration; Sympathetic outflow; Sympathetic reflex

Indexed keywords

EID: 84861471887     PISSN: 00836729     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-394623-2.00009-3     Document Type: Chapter

References (137)

1. Acuna-Goycolea C., van den Pol A. Glucagon-like peptide 1 excites hypocretin/orexin neurons by direct and indirect mechanisms: Implications for viscera-mediated arousal. J. Neurosci. 2004, 24:8141-8152.
2. Alexander S.P., Mathie A., Peters J.A. Guide to receptors and channels (GRAC). Br. J. Pharmacol. 2011, 164:S1-S324.
3. Antunes V.R., Cristina Brailoiu G., Kwok E.H., Scruggs P., Dun A.N.J. Orexins/hypocretins excite rat sympathetic preganglionic neurons in vivo and in vitro. Am. J. Physiol. 2001, 281:R1801-R1807.
4. Arihara Z., Takahashi K., Murakami O., Totsune K., Sone M., Satoh F., Ito S., Hayashi Y., Sasano H., Mouri T. Orexin-A in the human brain and tumor tissues of ganglioneuroblastoma and neuroblastoma. Peptides 2000, 21:565-570.
5. Bäckberg M., Hervieu G., Wilson S., Meister B. Orexin receptor-1 (OX-R1) immunoreactivity in chemically identified neurons of the hypothalamus: Focus on orexin targets involved in control of food and water intake. Eur. J. Neurosci. 2002, 15:315-328.
6. A receptor-mediated inhibition of the nucleus accumbens shell, but not by exposure to a novel environment. Eur. J. Neurosci. 2004, 19:376-386.
7. Bingham S., Davey P.T., Babbs A.J., Irving E.A., Sammons M.J., Wyles M., Jeffrey P., Cutler L., Riba I., Johns A., Porter R.A., Upton N., et al. Orexin-A, an hypothalamic peptide with analgesic properties. Pain 2001, 92:81-90.
8. Blanco M., García-Caballero T., Fraga M., Gallego R., Cuevas J., Forteza J., Beiras A., Diéguez C. Cellular localization of orexin receptors in human adrenal gland, adrenocortical adenomas and pheochromocytomas. Regul. Pept. 2002, 104:161-165.
9. Blanco M., López M., García-Caballero T., Gallego R., Vázquez-Boquete A., Morel G., Señarís R., Casanueva F., Diéguez C., Beiras A. Cellular localization of orexin receptors in human pituitary. J. Clin. Endocrinol. Metab. 2001, 86:3444-3447.
10. Borgland S.L., Taha S.A., Sarti F., Fields H.L., Bonci A. Orexin A in the VTA is critical for the induction of synaptic plasticity and behavioral sensitization to cocaine. Neuron 2006, 49:589-601.
11. Broberger C., De Lecea L., Sutcliffe J.G., Hökfelt T. Hypocretin/Orexin- and melanin-concentrating hormone-expressing cells form distinct populations in the rodent lateral hypothalamus: Relationship to the neuropeptide Y and agouti gene-related protein systems. J. Comp. Neurol. 1998, 402:460-474.
12. Brown R.E., Sergeeva O.A., Eriksson K.S., Haas H.L. Convergent excitation of dorsal raphe serotonin neurons by multiple arousal systems (orexin/hypocretin, histamine and noradrenaline). J. Neurosci. 2002, 22:8850-8859.
13. Burdakov D., Gerasimenko O., Verkhratsky A. Physiological changes in glucose differentially modulate the excitability of hypothalamic melanin-concentrating hormone and orexin neurons in situ. J. Neurosci. 2005, 25:2429-2433.
14. Cai X.J., Lister C.A., Buckingham R.E., Pickavance L., Wilding J., Arch J.R.S., Wilson S., Williams G. Down-regulation of orexin gene expression by severe obesity in the rats: Studies in Zucker fatty and Zucker diabetic fatty rats and effects of rosiglitazone. Mol. Brain Res. 2000, 77:131-137.
15. Cai X.J., Widdowson P.S., Harrold J., Wilson S., Buckingham R.E., Arch J.R., Tadayyon M., Clapham J.C., Wilding J., Williams G. Hypothalamic orexin expression: Modulation by blood glucose and feeding. Diabetes 1999, 48:2132-2137.
16. Chen C.T., Dun S.L., Kwok E.H., Dun N.J., Chang J.K. Orexin A-like immunoreactivity in the rat brain. Neurosci. Lett. 1999, 260:161-164.
17. Chen C.T., Hwang L.L., Chang J.K., Dun N.J. Pressor effects of orexins injected intracisternally and to rostral ventrolateral medulla of anesthetized rats. Am. J. Physiol. 2000, 278:R692-R697.
18. Ciriello J., de Oliveira C.V. Cardiac effects of hypocretin-1 in nucleus ambiguus. Am. J. Physiol. 2003, 284:R1611-R1620.
19. Ciriello J., Li Z., De Oliveira C.V.R. Cardioacceleratory responses to hypocretin-1 injections into rostral ventromedial medulla. Brain Res. 2003, 991:84-95.
20. Cluderay J.E., Harrison D.C., Hervieu G.J. Protein distribution of the orexin-2 receptor in the rat central nervous system. Regul. Pept. 2002, 104:131-144.
21. Corcoran A., Richerson G., Harris M., Homma I., Fukuchi Y., Onimaru H. Modulation of respiratory activity by hypocretin-1 (orexin A) in situ and in vitro. Adv. Exp. Med. Biol. 2010, 669:109-113.
22. Cutler D.J., Morris R., Sheridhar V., Wattam T.A.K., Holmes S., Patel S., Arch J.R.S., Wilson S., Buckingham R.E., Evans M.L., Leslie R.A., Williams G. Differential distribution of orexin-A and orexin-B immunoreactivity in the rat brain and spinal cord. Peptides 1999, 20:1455-1470.
23. Date Y., Mondal M.S., Matsukura S., Nakazato M. Distribution of orexin-A and orexin-B (hypocretins) in the rat spinal cord. Neurosci. Lett. 2000, 288:87-90.
24. Date Y., Ueta Y., Yamashita H., Yamaguchi H., Matsukura S., Kangawa K., Sakurai T., Yanagisawa M., Nakazato M. Orexins, orexigenic hypothalamic peptides, interact with autonomic, neuroendocrine and neuroregulatory systems. Proc. Natl. Acad. Sci. U.S.A. 1999, 96:748-753.
25. de Lecea L., Kilduff T.S., Peyron C., Gao X.-B., Foye P.E., Danielson P.E., Fukuhara C., Battenberg E.L.F., Gautvik V.T., Bartlett F.S., Frankel W.N., van den Pol A.N., et al. The hypocretins: Hypothalamus-specific peptides with neuroexcitatory activity. Proc. Natl. Acad. Sci. U.S.A. 1998, 95:322-327.
26. De Oliveira C.V.R., Rosas-Arellano M.P., Solano-Flores L.P., Ciriello J. Cardiovascular effects of hypocretin-1 in nucleus of the solitary tract. Am. J. Physiol. 2003, 284:H1369-H1377.
27. Deng B.S., Nakamura A., Zhang W., Yanagisawa M., Fukuda Y., Kuwaki T. Contribution of orexin in hypercapnic chemoreflex: Evidence from genetic and pharmacological disruption and supplementation studies in mice. J. Appl. Physiol. 2007, 103:1772-1779.
28. Dias M.B., Li A., Nattie E.E. Antagonism of orexin receptor-1 in the retrotrapezoid nucleus inhibits the ventilatory response to hypercapnia predominantly in wakefulness. J. Physiol. 2009, 587:2059-2067.
29. Dube M.G., Kalra S.P., Kalra P.S. Food intake elicited by central administration of orexins/hypocretins: Identification of hypothalamic sites of action. Brain Res. 1999, 842:473-477.
30. Dyer C.J., Touchette K.J., Carroll J.A., Allee G.L., Matteri R.L. Cloning of porcine prepro-orexin cDNA and effects of an intramuscular injection of synthetic porcine orexin-B on feed intake in young pigs. Domest. Anim. Endocrinol. 1999, 16:145-148.
31. Eggermann E., Serafin M., Bayer L., Machard D., Saint-Mleux B., Jones B.E., Muhlethaler M. Orexins/hypocretins excite basal forebrain cholinergic neurones. Neuroscience 2001, 108:177-181.
32. Elias C.F., Saper C.B., Maratos-Flier E., Tritos N.A., Lee C., Kelly J., Tatro J.B., Hoffman G.E., Ollmann M.M., Barsh G.S., Sakurai T., Yanagisawa M., et al. Chemically defined projections linking the mediobasal hypothalamus and the lateral hypothalamic area. J. Comp. Neurol. 1998, 402:442-459.
33. Fadel J., Deutch A.Y. Anatomical substrates of orexin-dopamine interactions: Lateral hypothalamic projections to the ventral tegmental area. Neuroscience 2002, 111:379-387.
34. Fu L.-Y., Acuna-Goycolea C., van den Pol A.N. Neuropeptide Y inhibits hypocretin/orexin neurons by multiple presynaptic and postsynaptic mechanisms: Tonic depression of the hypothalamic arousal system. J. Neurosci. 2004, 24:8741-8751.
35. Fujiki N., Yoshida Y., Ripley B., Honda K., Mignot E., Nishino S. Changes in CSF hypocretin-1 (orexin A) levels in rats across 24 hours and in response to food deprivation. Neuroreport 2001, 12:993-997.
36. Fung S.J., Yamuy J., Sampogna S., Morales F.R., Chase M.H. Hypocretin (orexin) input to trigeminal and hypoglossal motoneurons in the cat: A double-labeling immunohistochemical study. Brain Res. 2001, 903:257-262.
37. Galas L., Vaudry H., Braun B., Van Den Pol A.N., De Lecea L., Sutcliffe J.G., Chartrel N. Immunohistochemical localization and biochemical characterization of hypocretin/orexin-related peptides in the central nervous system of the frog Rana ridibunda. J. Comp. Neurol. 2001, 429:242-252.
38. Gallopin T., Fort P., Eggermann E., Cauli B., Luppi P.-H., Rossier J., Audinat E., Muhlethaler M., Serafin M. Identification of sleep-promoting neurons in vitro. Nature 2000, 404:992-995.
39. 2 chemoreception and integrated neural mechanisms of cardiovascular and respiratory control. J. Appl. Physiol. 2010, 108:995-1002.
40. Hagan J.J., Leslie R.A., Patel S., Evans M.L., Wattam T.A., Holmes S., Benham C.D., Taylor S.G., Routledge C., Hemmati P., Munton R.P., Ashmeade T.E., et al. Orexin A activates locus coeruleus cell firing and increases arousal in the rat. Proc. Natl. Acad. Sci. U.S.A. 1999, 96:10911-10916.
41. Hara J., Beuckmann C.T., Nambu T., Willie J.T., Chemelli R.M., Sinton C.M., Sugiyama F., Yagami K.-i., Goto K., Yanagisawa M., Sakurai T. Genetic ablation of orexin neurons in mice results in narcolepsy, hypophagia, and obesity. Neuron 2001, 30:345-354.
42. Harrison T.A., Chen C.T., Dun N.J., Chang J.K. Hypothalamic orexin A-immunoreactive neurons project to the rat dorsal medulla. Neurosci. Lett. 1999, 273:17-20.
43. Haynes A.C., Jackson B., Chapman H., Tadayyon M., Johns A., Porter R.A., Arch J.R.S. A selective orexin-1 receptor antagonist reduces food consumption in male and female rats. Regul. Pept. 2000, 96:45-51.
44. Hervieu G.J., Cluderay J.E., Harrison D.C., Roberts J.C., Leslie R.A. Gene expression and protein distribution of the orexin-1 receptor in the rat brain and spinal cord. Neuroscience 2001, 103:777-797.
45. Horvath T.L., Diano S., van den Pol A.N. Synaptic interaction between hypocretin (orexin) and neuropeptide Y cells in the rodent and primate hypothalamus: A novel circuit implicated in metabolic and endocrine regulations. J. Neurosci. 1999, 19:1072-1087.
46. Huang S.-C., Dai Y.-W.E., Lee Y.-H., Chiou L.-C., Hwang L.-L. Orexins depolarize rostral ventrolateral medulla neurons and increase arterial pressure and heart rate in rats mainly via orexin 2 receptors. J. Pharmacol. Exp. Ther. 2010, 334:522-529.
47. Huang Z.-L., Qu W.-M., Li W.-D., Mochizuki T., Eguchi N., Watanabe T., Urade Y., Hayaishi O. Arousal effect of orexin A depends on activation of the histaminergic system. Proc. Natl. Acad. Sci. U.S.A. 2001, 98:9965-9970.
48. Hungs M., Fan J., Lin L., Lin X., Maki R.A., Mignot E. Identification and functional analysis of mutations in the hypocretin (orexin) genes of narcoleptic canines. Genome Res. 2001, 11:531-539.
49. Ichinose M., Asai M., Sawada M., Sasaki K., Oomura Y. Induction of outward current by orexin-B in mouse peritoneal macrophages. FEBS Lett. 1998, 440:51-54.
50. Jöhren O., Neidert S.J., Kummer M., Dendorfer A., Dominiak P. Prepro-orexin and orexin receptor mRNAs are differentially expressed in peripheral tissues of male and female rats. Endocrinology 2001, 142:3324-3331.
51. Kastin A.J., Akerstrom V. Orexin A but not Orexin B rapidly enters brain from blood by simple diffusion. J. Pharmacol. Exp. Ther. 1999, 289:219-223.
52. Kayaba Y., Nakamura A., Kasuya Y., Ohuchi T., Yanagisawa M., Komuro I., Fukuda Y., Kuwaki T. Attenuated defense response and low basal blood pressure in orexin knockout mice. Am. J. Physiol. 2003, 285:R581-R593.
53. Kirchgessner A.L., Liu M.-t. Orexin synthesis and response in the gut. Neuron 1999, 24:941-951.
54. Korotkova T.M., Sergeeva O.A., Eriksson K.S., Haas H.L., Brown R.E. Excitation of ventral tegmental area dopaminergic and nondopaminergic neurons by orexins/hypocretins. J. Neurosci. 2003, 23:7-11.
55. Krout K.E., Mettenleiter T.C., Loewy A.D. Single CNS neurons link both central motor and cardiosympathetic systems: A double-virus tracing study. Neuroscience 2003, 118:853-866.
56. Lee M.G., Hassani O.K., Jones B.E. Discharge of identified orexin/hypocretin neurons across the sleep-waking cycle. J. Neurosci. 2005, 25:6716-6720.
57. Li Y., Gao X.B., Sakurai T., Van den Pol A.N. Hypocretin/orexin excites hypocretin neurons via a local glutamate neuron-A potential mechanism for orchestrating the hypothalamic arousal system. Neuron 2002, 36:1169-1181.
58. Li Y., van den Pol A.N. Differential target-dependent actions of coexpressed inhibitory dynorphin and excitatory hypocretin/orexin neuropeptides. J. Neurosci. 2006, 26:13037-13047.
59. Liu R.-J., van den Pol A.N., Aghajanian G.K. Hypocretins (orexins) regulate serotonin neurons in the dorsal raphe nucleus by excitatory direct and inhibitory indirect actions. J. Neurosci. 2002, 22:9453-9464.
60. Liu Z.-W., Gao X.-B. Adenosine inhibits activity of hypocretin/orexin neurons by the A1 receptor in the lateral hypothalamus: A possible sleep-promoting effect. J. Neurophysiol. 2007, 97:837-848.
61. Lopez M., Senaris R., Gallego R., Garcia-Caballero T., Lago F., Seoane L., Casanueva F., Dieguez C. Orexin receptors are expressed in the adrenal medulla of the rat. Endocrinology 1999, 140:5991-5994.
62. Lu J., Bjorkum A.A., Xu M., Gaus S.E., Shiromani P.J., Saper C.B. Selective activation of the extended ventrolateral preoptic nucleus during rapid eye movement sleep. J. Neurosci. 2002, 22:4568-4576.
63. Lu X.-Y., Bagnol D., Burke S., Akil H., Watson S.J. Differential distribution and regulation of OX1 and OX2 orexin/hypocretin receptor messenger RNA in the brain upon fasting. Horm. Behav. 2000, 37:335-344.
64. 2+ influx pathway necessary for coupling to phospholipase C. J. Biol. Chem. 2000, 275:30806-30812.
65. Ma X., Zubcevic L., Bruning J.C., Ashcroft F.M., Burdakov D. Electrical inhibition of identified anorexigenic POMC neurons by orexin/hypocretin. J. Neurosci. 2007, 27:1529-1533.
66. Machado B.H., Bonagamba L.G.H., Dun S.L., Kwok E.H., Dun N.J. Pressor response to microinjection of orexin/hypocretin into rostral ventrolateral medulla of awake rats. Regul. Pept. 2002, 104:75-81.
67. Malendowicz L.K., Hochol A., Ziolkowska A., Nowak M., Gottardo L., Nussdorfer G.G. Prolonged orexin administration stimulates steroid-hormone secretion, acting directly on the rat adrenal gland. Int. J. Mol. Med. 2001, 7:401-404.
68. Malendowicz L.K., Jedrzejczak N., Belloni A.S., Trejter M., Hochol A., Nussdorfer G.G. Effects of orexins A and B on the secretory and proliferative activity of immature and regenerating rat adrenal glands. Histol. Histopathol. 2001, 16:713-717.
69. Malendowicz L.K., Tortorella C., Nussdorfer G.G. Acute effects of orexins A and B on the rat pituitary-adrenocortical axis. Biomed. Res. 1999, 20:301-304.
70. Malendowicz L.K., Tortorella C., Nussdorfer G.G. Orexins stimulate corticosterone secretion of rat adrenocortical cells, through the activation of the adenylate cyclase-dependent signaling cascade. J. Steroid Biochem. Mol. Biol. 1999, 70:185-188.
71. Marcus J.N., Aschkenasi C.J., Lee C.E., Chemelli R.M., Saper C.B., Yanagisawa M., Elmquist J.K. Differential expression of orexin receptors 1 and 2 in the rat brain. J. Comp. Neurol. 2001, 435:6-25.
72. Matsuki T., Nomiyama M., Takahira H., Hirashima N., Kunita S., Takahashi S., Yagami K.I., Kilduff T.S., Bettler B., Yanagisawa M., Sakurai T. Selective loss of GABAB receptors in orexin-producing neurons results in disrupted sleep/wakefulness architecture. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:4459-4464.
73. Matsumura K., Tsuchihashi T., Abe I. Central orexin-A augments sympathoadrenal outflow in conscious rabbits. Hypertension 2001, 37:1382-1387.
74. Mazzocchi G., Malendowicz L.K., Gottardo L., Aragona F., Nussdorfer G.G. Orexin A stimulates cortisol secretion from human adrenocortical cells through activation of the adenylate cyclase-dependent signaling cascade. J. Clin. Endocrinol. Metab. 2001, 86:778-782.
75. Mikkelsen J.D., Hauser F., DeLecea L., Sutcliffe J.G., Kilduff T.S., Calgari C., Pévet P., Simonneaux V. Hypocretin (orexin) in the rat pineal gland: A central transmitter with effects on noradrenaline-induced release of melatonin. Eur. J. Neurosci. 2001, 14:419-425.
76. Mondal M.S., Nakazato M., Date Y., Murakami N., Yanagisawa M., Matsukura S. Widespread distribution of orexin in rat brain and its regulation upon fasting. Biochem. Biophys. Res. Commun. 1999, 256:495-499.
77. Muraki Y., Yamanaka A., Tsujino N., Kilduff T.S., Goto K., Sakurai T. Serotonergic regulation of the orexin/hypocretin neurons through the 5-HT1A receptor. J. Neurosci. 2004, 24:7159-7166.
78. 2+ signaling in a reciprocal manner to leptin: Orexigenic neuronal pathways in the mediobasal hypothalamus. Eur. J. Neurosci. 2004, 19:1524-1534.
79. Nakamura A., Zhang W., Yanagisawa M., Fukuda Y., Kuwaki T. Vigilance state-dependent attenuation of hypercapnic chemoreflex and exaggerated sleep apnea in orexin knockout mice. J. Appl. Physiol. 2007, 102:241-248.
80. Nakamura T., Uramura K., Nambu T., Yada T., Goto K., Yanagisawa M., Sakurai T. Orexin-induced hyperlocomotion and stereotypy are mediated by the dopaminergic system. Brain Res. 2000, 873:181-187.
81. Nambu T., Sakurai T., Mizukami K., Hosoya Y., Yanagisawa M., Goto K. Distribution of orexin neurons in the adult rat brain. Brain Res. 1999, 827:243-260.
82. Nanmoku T., Isobe K., Sakurai T., Yamanaka A., Takekoshi K., Kawakami Y., Goto K., Nakai T. Effects of orexin on cultured porcine adrenal medullary and cortex cells. Regul. Pept. 2002, 104:125-130.
83. Narita M., Nagumo Y., Hashimoto S., Narita M., Khotib J., Miyatake M., Sakurai T., Yanagisawa M., Nakamachi T., Shioda S., Suzuki T. Direct involvement of orexinergic systems in the activation of the mesolimbic dopamine pathway and related behaviors induced by morphine. J. Neurosci. 2006, 26:398-405.
84. Näslund E., Ehrström M., Ma J., Hellström P.M., Kirchgessner A.L. Localization and effects of orexin on fasting motility in the rat duodenum. Am. J. Physiol. 2002, 282:G470-G479.
85. Nowak K.W., Mackowiak P., Switonska M.M., Fabis M., Malendowicz L.K. Acute orexin effects on insulin secretion in the rat: In vivo and in vitro studies. Life Sci. 1999, 66:449-454.
86. Okumura T., Takeuchi S., Motomura W., Yamada H., Egashira S.-i., Asahi S., Kanatani A., Ihara M., Kohgo Y. Requirement of intact disulfide bonds in orexin-A-induced stimulation of gastric acid secretion that is mediated by OX1 receptor activation. Biochem. Biophys. Res. Commun. 2001, 280:976-981.
87. Peyron C., Faraco J., Rogers W., Ripley B., Overeem S., Charnay Y., Nevsimalova S., Aldrich M., Reynolds D., Albin R., Li R., Hungs M., et al. A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nat. Med. 2000, 6:991-997.
88. Peyron C., Tighe D.K., van den Pol A.N., de Lecea L., Heller H.C., Sutcliffe J.G., Kilduff T.S. Neurons containing hypocretin (orexin) project to multiple neuronal systems. J. Neurosci. 1998, 18:9996-10015.
89. Randeva H.S., Karteris E., Grammatopoulos D., Hillhouse E.W. Expression of orexin-A and functional orexin type 2 receptors in the human adult adrenals: Implications for adrenal function and energy homeostasis. J. Clin. Endocrinol. Metab. 2001, 86:4808-4813.
90. Ripley B., Fujiki N., Okura M., Mignot E., Nishino S. Hypocretin levels in sporadic and familial cases of canine narcolepsy. Neurobiol. Dis. 2001, 8:525-534.
91. Rodgers R.J., Halford J.C.G., Nunes de Souza R.L., Canto de Souza A.L., Piper D.C., Arch J.R.S., Upton N., Porter R.A., Johns A., Blundell J.E. SB-334867, a selective orexin-1 receptor antagonist, enhances behavioural satiety and blocks the hyperphagic effect of orexin-A in rats. Eur. J. Neurosci. 2001, 13:1444-1452.
92. Rosin D.L., Chang D.A., Guyenet P.G. Afferent and efferent connections of the rat retrotrapezoid nucleus. J. Comp. Neurol. 2006, 499:64-89.
93. Russell S.H., Kim M.S., Small C.J., Abbott C.R., Morgan D.G.A., Taheri S., Murphy K.G., Todd J.F., Ghatei M.A., Bloom S.R. Central administration of orexin A suppresses basal and domperidone stimulated plasma prolactin. J. Neuroendocrinol. 2000, 12:1213-1218.
94. Sakurai T. Reverse pharmacology of orexin: From an orphan GPCR to integrative physiology. Regul. Pept. 2005, 126:3-10.
95. Sakurai T., Amemiya A., Ishii M., Matsuzaki I., Chemelli R.M., Tanaka H., Williams S.C., Richarson J.A., Kozlowski G.P., Wilson S., Arch J.R., Buckingham R.E., et al. Orexins and orexin receptors: A family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 1998, 92:573-585.
96. Sakurai T., Moriguchi T., Furuya K., Kajiwara N., Nakamura T., Yanagisawa M., Goto K. Structure and function of human prepro-orexin gene. J. Biol. Chem. 1999, 274:17771-17776.
97. Sakurai T., Nagata R., Yamanaka A., Kawamura H., Tsujino N., Muraki Y., Kageyama H., Kunita S., Takahashi S., Goto K., Koyama Y., Shioda S., et al. Input of orexin/hypocretin neurons revealed by a genetically encoded tracer in mice. Neuron 2005, 46:297-308.
98. Samson W.K., Gosnell B., Chang J.K., Resch Z.T., Murphy T.C. Cardiovascular regulatory actions of the hypocretins in brain. Brain Res. 1999, 831:248-253.
99. Shahid I.Z., Rahman A.A., Pilowsky P.M. Intrathecal orexin A increases sympathetic outflow and respiratory drive, enhances baroreflex sensitivity and blocks the somato-sympathetic reflex. Br. J. Pharmacol. 2011, 162:961-973.
100. Shahid I.Z., Rahman A.A., Pilowsky P.M. Orexin A in rat rostral ventrolateral medulla is pressor, sympathoexcitatory, increases barosensitivity and attenuates the somatosympathetic reflex. Br. J. Pharmacol. 2012, 165:2292-2303.
101. Sherin J.E., Elmquist J.K., Torrealba F., Saper C.B. Innervation of histaminergic tuberomammillary neurons by GABAergic and galaninergic neurons in the ventrolateral preoptic nucleus of the rat. J. Neurosci. 1998, 18:4705-4721.
102. Shibahara M., Sakurai T., Nambu T., Takenouchi T., Iwaasa H., Egashira S.-I., Ihara M., Goto K. Structure, tissue distribution, and pharmacological characterization of Xenopus orexins. Peptides 1999, 20:1169-1176.
103. Shih C.D., Chuang Y.C. Nitric oxide and GABA mediate bi-directional cardiovascular effects of orexin in the nucleus tractus solitarii of rats. Neuroscience 2007, 149:625-635.
104. Shirasaka T., Nakazato M., Matsukura S., Takasaki M., Kannan H. Sympathetic and cardiovascular actions of orexins in conscious rats. Am. J. Physiol. 1999, 277:R1780-R1785.
105. Smart D., Jerman J.C., Brough S.J., Neville W.A., Jewitt F., Porter R.A. The hypocretins are weak agonists at recombinant human orexin-1 and orexin-2 receptors. Br. J. Pharmacol. 2000, 129:1289-1291.
106. Smart D., Jerman J.C., Brough S.J., Rushton S.L., Murdock P.R., Jewitt F., Elshourbagy N.A., Ellis C.E., Middlemiss D.N., Brown F. Characterization of recombinant human orexin receptor pharmacology in a Chinese hamster ovary cell-line using FLIPR. Br. J. Pharmacol. 1999, 128:1-3.
107. Smith P.M., Connolly B.C., Ferguson A.V. Microinjection of orexin into the rat nucleus tractus solitarius causes increases in blood pressure. Brain Res. 2002, 950:261-267.
108. Stornetta R.L., Spirovski D., Moreira T.S., Takakura A.C., West G.H., Gwilt J.M., Pilowsky P.M., Guyenet P.G. Galanin is a selective marker of the retrotrapezoid nucleus in rats. J. Comp. Neurol. 2009, 512:373-383.
109. 2 activates orexin-containing neurons in mice. Respir. Physiol. Neurobiol. 2009, 166:184-186.
110. Sunter D., Morgan I., Edwards C.M.B., Dakin C.L., Murphy K.G., Gardiner J., Taheri S., Rayes E., Bloom S.R. Orexins: Effects on behavior and localisation of orexin receptor 2 messenger ribonucleic acid in the rat brainstem. Brain Res. 2001, 907:27-34.
111. Sutcliffe J.G., De Lecea L. The hypocretins: Excitatory neuromodulatory peptides for multiple homeostatic systems, including sleep and feeding. J. Neurosci. Res. 2000, 62:161-168.
112. Thannickal T.C., Moore R.Y., Nienhuis R., Ramanathan L., Gulyani S., Aldrich M., Cornford M., Siegel J.M. Reduced number of hypocretin neurons in human narcolepsy. Neuron 2000, 27:469-474.
113. Thorpe A.J., Kotz C.M. Orexin A in the nucleus accumbens stimulates feeding and locomotor activity. Brain Res. 2005, 1050:156-162.
114. Toyama S., Sakurai T., Tatsumi K., Kuwaki T. Attenuated phrenic long-term facilitation in orexin neuron-ablated mice. Respir. Physiol. Neurobiol. 2009, 168:295-302.
115. Trivedi P., Yu H., MacNeil D.J., Van Der Ploeg L.H.T., Guan X.M. Distribution of orexin receptor mRNA in the rat brain. FEBS Lett. 1998, 438:71-75.
116. Tsujino N., Yamanaka A., Ichiki K., Muraki Y., Kilduff T.S., Yagami K.-i., Takahashi S., Goto K., Sakurai T. Cholecystokinin activates orexin/hypocretin neurons through the cholecystokinin a receptor. J. Neurosci. 2005, 25:7459-7469.
117. van den Pol A.N. Hypothalamic hypocretin (orexin): Robust innervation of the spinal cord. J. Neurosci. 1999, 19:3171-3182.
118. van den Pol A.N., Gao X.-B., Obrietan K., Kilduff T.S., Belousov A.B. Presynaptic and postsynaptic actions and modulation of neuroendocrine neurons by a new hypothalamic peptide, hypocretin/orexin. J. Neurosci. 1998, 18:7962-7971.
119. van den Top M., Lee K., Whyment A.D., Blanks A.M., Spanswick D. Orexigen-sensitive NPY/AgRP pacemaker neurons in the hypothalamic arcuate nucleus. Nat. Neurosci. 2004, 7:493-494.
120. van den Top M., Nolan M.F., Lee K., Richardson P.J., Buijs R.M., Davies C.H., Spanswick D. Orexins induce increased excitability and synchronisation of rat sympathetic preganglionic neurones. J. Physiol. 2003, 549:809-821.
121. Vanni-Mercier G., Sakai K., Jouvet M. 'Waking-state specific' neurons in the caudal hypothalamus of the cat. C. R. Acad. Sci. III 1984, 298:195-200.
122. Volgin D.V., Saghir M., Kubin L. Developmental changes in the orexin 2 receptor mRNA in hypoglossal motoneurons. Neuroreport 2002, 13:433-436.
123. 2 . Proc. Natl. Acad. Sci. U.S.A. 2007, 104:10685-10690.
124. Willie J.T., Chemelli R.M., Sinton C.M., Tokita S., Williams S.C., Kisanuki Y.Y., Marcus J.N., Lee C., Elmquist J.K., Kohlmeier K.A., Leonard C.S., Richardson J.A., et al. Distinct narcolepsy syndromes in orexin receptor-2 and orexin null mice: Molecular genetic dissection of non-REM and REM sleep regulatory processes. Neuron 2003, 38:715-730.
125. Willie J.T., Chemelli R.M., Sinton C.M., Yanagisawa M. To eat or to sleep? Orexin in the regulation of feeding and wakefulness. Annu. Rev. Neurosci. 2001, 24:429-458.
126. Winsky-Sommerer R.l., Yamanaka A., Diano S., Borok E., Roberts A.J., Sakurai T., Kilduff T.S., Horvath T.L., de Lecea L. Interaction between the corticotropin-releasing factor system and hypocretins (orexins): A novel circuit mediating stress response. J. Neurosci. 2004, 24:11439-11448.
127. B receptor-mediated modulation of hypocretin/orexin neurones in mouse hypothalamus. J. Physiol. 2006, 574:399-414.
128. Yamada H., Okumura T., Motomura W., Kobayashi Y., Kohgo Y. Inhibition of food intake by central injection of anti-orexin antibody in fasted rats. Biochem. Biophys. Res. Commun. 2000, 267:527-531.
129. Yamanaka A., Beuckmann C.T., Willie J.T., Hara J., Tsujino N., Mieda M., Tominaga M., Yagami K.-i., Sugiyama F., Goto K., Yanagisawa M., Sakurai T. Hypothalamic orexin neurons regulate arousal according to energy balance in mice. Neuron 2003, 38:701-713.
130. Yamanaka A., Kunii K., Nambu T., Tsujino N., Sakai A., Matsuzaki I., Miwa Y., Katsutoshi G., Sakurai T. Orexin-induced food intake involves neuropeptide Y pathway. Brain Res. 2000, 859:404-409.
131. Yamanaka A., Muraki Y., Ichiki K., Tsujino N., Kilduff T.S., Goto K., Sakurai T. Orexin neurons are directly and indirectly regulated by catecholamines in a complex manner. J. Neurophysiol. 2006, 96:284-298.
132. Yamanaka A., Muraki Y., Tsujino N., Goto K., Sakurai T. Regulation of orexin neurons by the monoaminergic and cholinergic systems. Biochem. Biophys. Res. Commun. 2003, 303:120-129.
133. Yamanaka A., Tsujino N., Funahashi H., Honda K., Guan J.-l., Wang Q.-P., Tominaga M., Goto K., Shioda S., Sakurai T. Orexins activate histaminergic neurons via the orexin 2 receptor. Biochem. Biophys. Res. Commun. 2002, 290:1237-1245.
134. Yang Z.-J., Meguid M.M., Chai J.-K., Chen C., Oler A. Bilateral hypothalamic dopamine infusion in male zucker rat suppresses feeding due to reduced meal size. Pharmacol. Biochem. Behav. 1997, 58:631-635.
135. Yoshida K., McCormack S., España R.A., Crocker A., Scammell T.E. Afferents to the orexin neurons of the rat brain. J. Comp. Neurol. 2006, 494:845-861.
136. Young J.K., Wu M., Manaye K.F., Kc P., Allard J.S., Mack S.O., Haxhiu M.A. Orexin stimulates breathing via medullary and spinal pathways. J. Appl. Physiol. 2005, 98:1387-1395.
137. Zhang W., Fukuda Y., Kuwaki T. Respiratory and cardiovascular actions of orexin-A in mice. Neurosci. Lett. 2005, 385:131-136.